DrugDashboards

Xtoro

finafloxacin · FINAFLOXACIN 3 mg/mL · Suspension · Auricular (Otic) · Fonseca Biosciences, LLC

NDC 83709-0001-01 · 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$695.00
Reported to Texas DSHS · 2026 annual filing · Fonseca Biosciences LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA206307
TE code
Approval date
Dec 17, 2014
Patents / exclusivity
4 patents, 0 exclusivities
TypeNumber / codeExpires
patent9504691Nov 21, 2033
patent8536167Aug 8, 2031
patent9119859Jul 2, 2030
patent9993483Jul 2, 2030

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of finafloxacin (Suspension)

LabelerStrengthFirst seenLast seen
Fonseca Biosciences, LLCFINAFLOXACIN 3 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Xtoro — NDC 83709-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/83709000101.

Free to cite with attribution — see how the data is put together.